Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines

Dual-probe fluorescence in situ hybridization (D-FISH) is a widely accepted method to determine the gene amplification status of human epidermal growth factor receptor 2 (Her-2). In 2013, the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) updated the guidelines on...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Cancer Res Treat
Auteurs principaux: Qian, Xiao-Long, Wen, Hannah Y., Yang, Yi-Ling, Gu, Feng, Guo, Xiao-Jing, Liu, Fang-Fang, Zhang, Lanjing, Zhang, Xin-Min, Fu, Li
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600490/
https://ncbi.nlm.nih.gov/pubmed/27455837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3917-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires